Volume 76, Issue 9, Pages (November 2009)

Slides:



Advertisements
Similar presentations
Volume 82, Issue 12, Pages (December 2012)
Advertisements

LDL cholesterol in CKD—to treat or not to treat?
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /
Nutrition and chronic kidney disease
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Volume 77, Pages S2-S8 (March 2010)
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 375, Issue 9709, Pages (January 2010)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Volume 79, Issue 9, Pages (May 2011)
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
FGF23 or PTH: which comes first in CKD ?
C-reactive protein and dialysis access
Volume 79, Issue 2, Pages (January 2011)
Shining light on vitamin D trials in chronic kidney disease
Volume 68, Issue 2, Pages (August 2005)
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
Reassessment of the care of the patient with chronic kidney disease
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.
C-reactive protein and dialysis access
John P. Middleton, Patrick H. Pun  Kidney International 
Type of vascular access and mortality in U.S. hemodialysis patients
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Volume 82, Issue 12, Pages (December 2012)
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Volume 86, Issue 4, Pages (October 2014)
Volume 88, Issue 2, Pages (August 2015)
Volume 79, Pages S9-S13 (April 2011)
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.
Volume 81, Issue 3, Pages (February 2012)
Volume 93, Issue 1, Pages (January 2018)
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Ian H. de Boer, Rajnish Mehrotra  Kidney International 
Volume 84, Issue 5, Pages (November 2013)
Nutrition and chronic kidney disease
Volume 74, Issue 3, Pages (August 2008)
Survival advantage in Asian American end-stage renal disease patients1
Volume 70, Issue 11, Pages (December 2006)
Use of vitamin D in chronic kidney disease patients
Volume 67, Issue 3, Pages (March 2005)
Dyslipidemia in children with chronic kidney disease
Volume 62, Issue 6, Pages (December 2002)
Study of Heart and Renal Protection (SHARP)
Pieter Evenepoel, Björn K. Meijers  Kidney International 
U-shaped effect of eGFR and mortality
LDL cholesterol in CKD—to treat or not to treat?
Body size and outcomes on peritoneal dialysis in the United States
Volume 86, Issue 3, Pages (September 2014)
Volume 73, Issue 12, Pages (June 2008)
Methods for guideline development
Volume 87, Issue 1, Pages (January 2015)
Volume 67, Issue 4, Pages (April 2005)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 73, Issue 8, Pages (April 2008)
Volume 77, Issue 12, Pages (June 2010)
Volume 64, Issue 2, Pages (August 2003)
Volume 72, Issue 2, Pages (July 2007)
Volume 80, Issue 10, Pages (November 2011)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Cardiovascular risk in chronic kidney disease
Volume 75, Issue 1, Pages (January 2009)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Vitamin D deficiency and anemia in early chronic kidney disease
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 76, Issue 5, Pages (September 2009)
Volume 74, Issue 10, Pages (November 2008)
Presentation transcript:

Volume 76, Issue 9, Pages 977-983 (November 2009) Chronic kidney disease, hypovitaminosis D, and mortality in the United States  Rajnish Mehrotra, Dulcie A. Kermah, Isidro B. Salusky, Myles S. Wolf, Ravi I. Thadhani, Yi-Wen Chiu, David Martins, Sharon G. Adler, Keith C. Norris  Kidney International  Volume 76, Issue 9, Pages 977-983 (November 2009) DOI: 10.1038/ki.2009.288 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Adjusted hazards ratios for all-cause mortality, adjusted for demographics and cardiovascular risk factors, among different subgroups of the participants in the Third National Health and Nutrition Examination Survey. The risk for all-cause mortality is reported for individuals with serum 25-hydroxy vitamin D levels <15ng/ml compared with those with levels >30ng/ml. For each subgroup analysis, data were adjusted for each of the other variables; current smoking, month of year, and family history of cardiovascular disease were included in each subgroup analysis. BMI, body mass index; CHOL, cholesterol; CKD, chronic kidney disease; CRP, C-reactive protein; CVD, cardiovascular disease; DM, diabetes mellitus; HDL, high-density lipoprotein. Kidney International 2009 76, 977-983DOI: (10.1038/ki.2009.288) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted hazards ratios for all-cause mortality, adjusted for demographics and cardiovascular risk factors, among different subgroups of the participants in the Third National Health and Nutrition Examination Survey. The risk for all-cause mortality is reported for individuals with serum 25-hydroxy vitamin D levels 15–30ng/ml compared with those with levels >30ng/ml. For each subgroup analysis, data were adjusted for each of the other variables; current smoking, month of year, and family history of cardiovascular disease were included in each subgroup analysis. BMI, body mass index; CHOL, cholesterol; CKD, chronic kidney disease; CRP, C-reactive protein; CVD, cardiovascular disease; DM, diabetes mellitus; HDL, high-density lipoprotein. Kidney International 2009 76, 977-983DOI: (10.1038/ki.2009.288) Copyright © 2009 International Society of Nephrology Terms and Conditions